What Are Common Pitfalls in Writing PCT Grant Applications?
Rethinking Clinical Trials
OCTOBER 19, 2023
The post What Are Common Pitfalls in Writing PCT Grant Applications? appeared first on Rethinking Clinical Trials.
Thu.Oct 19, 2023
100 
Beam to lay off 100 employees, seek partners in research restructuring
Bio Pharma Dive
OCTOBER 19, 2023
The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
EC expands Takeda’s Adcetris label for advanced Hodgkin lymphoma treatment
Pharmaceutical Technology
OCTOBER 19, 2023
Adcetris/AVD is already approved as a first-line treatment for patients with CD30+ Stage IV Hodgkin lymphoma.
Spicy Food Can Be Extremely Painful, But Is It Actually Dangerous?
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 19, 2023
Everyone has a different tolerance for spicy food — some love the burn, while others can’t take the heat. But the scientific consensus on whether spicy food can have an effect — positive or negative — on your health is pretty mixed.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PTC to sell spinal muscular atrophy drug royalties for $1B
Bio Pharma Dive
OCTOBER 19, 2023
A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.
Parliamentary panel asks govt to consider comprehensive policy framework to eliminate TB
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 19, 2023
A Parliamentary panel that looked into the implementation of Pradhan Mantri TB Mukt Bharat Abhiyan (PMTBMBA) has recommended to the government to consider developing a comprehensive policy framework emphasising on public-private partnership to eradicate Tuberculosis from the country.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Neuronopathic therapies are a serious unmet need in the treatment of Gaucher disease
Pharmaceutical Technology
OCTOBER 19, 2023
KOLs interviewed by GlobalData emphasised a significant lack of neuronopathic therapies in the Gaucher disease landscape.
Laronde, Senda Biosciences merge to create new Flagship company
Bio Pharma Dive
OCTOBER 19, 2023
The troubled RNA biotech is merging with Senda, another Flagship company that has drawn hundreds of millions of dollars in investment.
AN2 Therapeutics receives licence to develop Chagas disease therapy
Pharmaceutical Technology
OCTOBER 19, 2023
AN2 Therapeutics has signed an agreement for advancing the development of a new boron-containing small molecule to treat Chagas disease.
WHO releases key regulatory considerations on AI for health
Pharma Times
OCTOBER 19, 2023
The considerations will help to develop new or existing guidance on AI - News - PharmaTimes
Q3 2023 update: environmental sustainability related hiring actvity in the pharma industry
Pharmaceutical Technology
OCTOBER 19, 2023
The global pharmaceutical industry recorded a 11% drop in environmental sustainability hiring activity in Q3 2023, according to GlobalData
Gilead’s Biktarvy reinforced as a treatment option for HIV
Pharma Times
OCTOBER 19, 2023
HIV affects approximately 39 million people worldwide and can lead to AIDS - News - PharmaTimes
How did hiring in the North American pharma industry perform in Q3 2023?
Pharmaceutical Technology
OCTOBER 19, 2023
The North American pharma industry experienced a 26% drop in hiring activity in Q3 2023, led by CSL's 11% share, according to GlobalData
ESMO: In PD-1 battle GSK waged on Merck, Jemperli appears to show survival edge over Keytruda in lung cancer
Fierce Pharma
OCTOBER 19, 2023
Last year, a first-of-its-kind head-to-head clinical trial between two PD-1 inhibitors went in GSK’s favor. Now, the British pharma has some new patient survival data to celebrate. | Last year, a first-of-its-kind head-to-head clinical trial between two PD-1 inhibitors went in GSK’s favor. Now, the British pharma has some new patient survival data to celebrate.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
How did hiring in the French pharma industry perform in Q3 2023?
Pharmaceutical Technology
OCTOBER 19, 2023
The French pharma industry experienced a 39% drop in new job postings in Q3 2023 compared with the previous quarter,…
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
OCTOBER 19, 2023
After trimming an early-stage Crohn’s disease candidate from i | After trimming an early-stage Crohn’s disease candidate from its pipeline this year, Takeda is dealing with the failure of another of its therapies in a related indication. Alofisel (daradstrocel), a stem cell therapy designed to treat one of the most debilitating complications of Crohn’s—complex perianal fistulas (CPF)—has come up short in a phase 3 trial.
How did hiring in the North American pharma industry perform in Q3 2023?
Pharmaceutical Technology
OCTOBER 19, 2023
The North American pharma industry experienced a 26% drop in hiring activity in Q3 2023, led by CSL's 11% share, according to GlobalData
EU, UK authorities crack down on fake versions of Novo Nordisk's Ozempic
Fierce Pharma
OCTOBER 19, 2023
As Novo Nordisk works to get a handle on sales of illicit semaglutide, British and European drug authorities are warning that they've discovered falsified Ozempic pens on their home turf. | Novo Nordisk's hugely popular diabetes and weight-loss meds have attracted their share of counterfeits. Now, British and European drug authorities are warning that they've discovered falsified Ozempic pens on their home turf.
Stuart Therapeutics and Glaukos sign deal for glaucoma drug candidate
Pharmaceutical Technology
OCTOBER 19, 2023
Stuart Therapeutics and Glaukos have signed a licence agreement for the former’s ST-113 drug candidate for neuroprotection in glaucoma.
Pfizer sets Paxlovid price at nearly $1,400 per course
pharmaphorum
OCTOBER 19, 2023
Pfizer sets Paxlovid price at nearly $1,400 per course Phil.
Cessation receives grant to develop anti-fentanyl mAb formulation
Pharmaceutical Technology
OCTOBER 19, 2023
Cessation Therapeutics has received a grant from NIDA to develop a subcutaneous formulation of the anti-fentanyl mAb, CSX-1004 SQ.
Key breast cancer facts for Breast Cancer Awareness Month
Antidote
OCTOBER 19, 2023
Since 1985, Breast Cancer Awareness Month has been held every October with the goal of raising awareness about the importance of breast cancer screening and prevention. Catching breast cancer early is one of the best ways to increase a person’s prognosis — though one in 8 women in the United States will be diagnosed with breast cancer in their lifetime , when caught in early stages, the 5-year survival rate is 99%.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Novavax obtains full marketing authorisation in UK for Nuvaxovid
Pharmaceutical Technology
OCTOBER 19, 2023
Novavax has received full marketing authorisation from the UK’s MHRA for its prototype Covid-19 vaccine Nuvaxovid (NVX-CoV2373).
Lilly makes another ADC play, buying Mablink
pharmaphorum
OCTOBER 19, 2023
Lilly makes another ADC play, buying Mablink Phil.
How did hiring in the pharma industry perform in Q3 2023?
Pharmaceutical Technology
OCTOBER 19, 2023
The global pharma industry recorded a 31% drop in hiring activity in Q3 2023, led by CSL's 7% share, according to GlobalData
One Health: The interconnection of animal and human health
pharmaphorum
OCTOBER 19, 2023
One Health: The interconnection of animal and human health Mike.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PTC inks Royalty deal worth up to $1.5B on Genentech-partnered SMA drug Evrydsi
Fierce Pharma
OCTOBER 19, 2023
Amid a cost-cutting drive and a looming commercial threat in Europe, PTC Ther | PTC will hold on to 19% of its royalty interest in the Genentech drug with the option to sell the rest down the line. The company licensed the med to Genentech in 2011.
How generative AI Is transforming healthcare
pharmaphorum
OCTOBER 19, 2023
How generative AI Is transforming healthcare Mike.
Merck Pays $4B Upfront for Daiichi Sankyo’s DXd-Based ADCs
BioSpace
OCTOBER 19, 2023
Seeking to deepen its immuno-oncology business, Merck has closed a deal potentially worth $22 billion across three of Daiichi Sankyo’s DXd antibody-drug conjugates for various solid tumor indications.
The Role of Financial Management and GAAP in Clinical Research
ACRP blog
OCTOBER 19, 2023
This is a sponsored message. Research sites play a pivotal role in clinical trials in that they are responsible for participant recruitment, data collection, safety monitoring, regulatory management, overall trial conduct, and more. However, in order to maintain a successful research program and ensure long-term growth, a site also needs to focus on running itself as a business.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content